Gatipotuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade

Reference:
Product nameGatipotuzumab Biosimilar - Anti-MUC1, CD227 mAb - Research Grade
SourceCAS 1264737-26-9
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsGatipotuzumab,PankoMab,PankoMab-GEX,hPankoMab,MUC1, CD227,anti-MUC1, CD227
ReferencePX-TA1475
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Gatipotuzumab Biosimilar - Anti-MUC1/CD227 mAb - Research Grade

About Gatipotuzumab biosimilar

Gatipotuzumab is a humanized monoclonal antibody, wih a specific glycosylation. It is able to recognize a tumor-specific epitope expressed on the surface of epithelial tumor cells. This target is an abnormal glycosylation on mucin-1, a glycosylated protein protecting epithelial surfaces. This tumor specific epitope is called TA-MUC1 and is overexpressed in epithelial cancer. Gatipotuzumab should have then an anti-tumor activity which has been already proved in a first clinical trial of phase I.Gatipotuzumab is able to distinguish between tumor MUC1 and non-tumor MUC1 epitopes. Its bond to the TA-MUC1 epitope induces Antibody-dependent cell-mediated cytotoxicity (ADCC) against epithelial tumor cells expressing this epitope. ADCC is a defense mechanism of the immune system.

About anti MUC1 activity

Gatipotuzumab is developed with a specific glycosylation process which is altering the glycosylation in the Fc region of the monoclonal antibody molecule. This development enhances immunogenicity and causes a stronger ADCC response.

About Mucins

Mucins are O-glycosylated proteins playing an overriding role in the protection of epithelial surfaces, by creating mucous barriers. These proteins also are intracellular signaling factors, and are expressed on the apical surface of epithelial cells that are found on the mucosal surfaces. Mucins are cleaved into two subunits (alpha and beta) by proteolysis: these subunits form a heterodimer. The N-terminal alpha subunit is involved in cell-adhesion; the C-terminal beta subunit is meanwhile involved in cell signaling.

SDS-PAGE for Gatipotuzumab Biosimilar - Anti-MUC1, CD227 mAb

Gatipotuzumab Biosimilar - Anti-MUC1, CD227 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Publication

  • Yunliang Chen, Michael Scully, Tumour-associated Mucin1 correlates with the procoagulant properties of cancer cells of epithelial origin,Thrombosis Update,Volume 9,2022,100123,ISSN 2666-5727,https://doi.org/10.1016/j.tru.2022.100123.(https://www.sciencedirect.com/science/article/pii/S266657272200027X)

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Gatipotuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Mucin-1(Met1-Pro146)
Antigen

Mucin-1(Met1-Pro146)

PX-P4728 210€
Mucin-1(Ala927-Gly1158)
Antigen

Mucin-1(Ala927-Gly1158)

PX-P4729 210€
Mucin-1(Ser24-Pro146)
Antigen

Mucin-1(Ser24-Pro146)

PX-P4730 210€
Mucin-1(Thr931-Gly1158)
Antigen

Mucin-1(Thr931-Gly1158)

PX-P4731 210€
Stable Isotope Labelled Gatipotuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade
SIL

Stable Isotope Labelled Gatipotuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade

PX-TA1475-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products